SINCE

— 1995 —

CULTURE

Mission: ……embrace life with energy.

Sprits: Innovation, Modernization, Perseverance, Responsibility

Development concepts: Leading technology, paramount quality, advanced standard, scientific management.

Vision: A specialized, globalized and leading enterprise of IV iron and branded generic drugs for nephrology.

ＨONOR

Nanjing Hencer Pharmaceutical Co., Ltd, established in 1995, is an innovative high-tech enterprise incorporates R&D, manufacture and sales. Hencer has 356 employees, 40% of which have college degree or above. Staffs in every post are professional and experienced. The combination of talent and techniques make Hencer stand out from Chinese pharmaceutical industry.

Hencer has been named Research Center of Polysaccharide Iron Compound Medicine in Jiangsu Province, Private Scientific and Technical Enterprise in Jiangsu Province and Credit-Worthy Enterprise in Jiangsu Province.

Nanjing Hencer Pharmaceutical Co. Ltd. steadfastly upholds the spirit of development, which is “always give prior consideration to technology, put quality of products at a paramount place, lead the industry standard and manage scientifically,” on the lead of science, with the core of characteristic products, with knowledge marketing as impetus, to build a leading enterprise focusing on IV iron and branded generic nephrology products.

Hencer’s Manufacturing Center locates in Lishui Economic & Technological Development Zone, Nanjing; the R&D center, namely, Nanjing Lifenergy R&D Co., Ltd, locates in Nanjing Economic & Technical Development Zone; Domestic Marketing Division is located in Changfa Building and International Business Division is located in Golden Eagle Hanzhong Garden.

Hencer and Lifenergy focus on nephrology and cardio-cerebrovascular. Our core products, Iron Sucrose Injection, Ibandronate Sodium Injection and Phloroglucinol Injection, were the first to enter the domestic market and been sold to overseas market.

Compound Earthworm Capsules and Xintongkang Capsules are “Exclusive Protection Varieties of Traditional Chinese Medicine”. Compound Earthworm Capsules is the Hencer’s exclusive product and is the only compound preparation traditional Chinese medicine containing Lumbrukinase being approved by CFDA.

Hencer always targets at the development frontier of high technology. To make the products’ quality and technological level meet the requirements of advanced international standard and become the flagship of Chinese pharmaceutical industry, Hencer keeps enhancing the strength of development, establishing the R&D concept which adapts to global strategy, improving products’ quality and economic efficiency and expanding the export scale.

HISTORY

1972, Lishui Pharmaceutical Factory established.

 

1994, Nanjing Pharmaceutical Group merged Lishui Pharmaceutical Factory

 

1995, Lishui Pharmaceutical Factory was renamed Nanjing Hencer Pharmaceutical Factory

 

1999, Compound Earthworm Capsules was the first to be approved for the listing and became “Exclusive Protection Varieties of Traditional Chinese Medicine”.

 

2001, Ibandronate Sodium Injection was approved for the list. It is the first approved ANDA in China.

 

2002, Xintongkang Capsules was the first to be approved for the listing and became “Exclusive Protection Varieties of Traditional Chinese Medicine”.

 

2004, Iron Sucrose Injection was approved for the list. It is the first ANDA in China and shortened the gap between China and developed countries in IV iron area.

 

2004, Phloroglucinol Injection was approved for the list. It is the first ANDA in China and provided treatment with the same quality but lower price to patients who need symptomatic treatment.

 

2007, Ketoacid products started to export. Hencer was determined to become a leading company with specialized and globalized branded nephrology products according to the idea of “developing trade with technology, promoting technology of trade.”

 

2012, Nanjing Hencer Pharmaceutical Factory renamed Nanjing Hencer Pharmaceutical Co., Ltd. R&D, manufacturing, marketing and management have been upgraded.

 

2015, Nanjing Hencer Pharmaceutical Co., Ltd assigned 100% equity of Nanjing Lifenergy R&D Co., Ltd and achieved extension of industry chain and integration between R&D and manufacturing.

 

2016, Hencer established Research Center of Polysaccharide Iron Compound Medicine in Jiangsu Province.

 

 

 

荣誉资质